BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31029532)

  • 1. A review of the histopathological findings in myasthenia gravis: Clues to the pathogenesis of treatment-resistance in extraocular muscles.
    Europa TA; Nel M; Heckmann JM
    Neuromuscul Disord; 2019 May; 29(5):381-387. PubMed ID: 31029532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraocular Muscle Findings in Myasthenia Gravis Associated Treatment-Resistant Ophthalmoplegia.
    Rautenbach RM; Pillay K; Murray ADN; Heckmann JM
    J Neuroophthalmol; 2017 Dec; 37(4):414-417. PubMed ID: 28742638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudo-internuclear ophthalmoplegia with downshoot in myasthenia gravis.
    Jay WM; Nazarian SM; Underwood DW
    J Clin Neuroophthalmol; 1987 Jun; 7(2):74-6. PubMed ID: 2956287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles.
    Serra A; Ruff R; Kaminski H; Leigh RJ
    Ann N Y Acad Sci; 2011 Sep; 1233():26-33. PubMed ID: 21950972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular aspects of myasthenia gravis.
    Barton JJ; Fouladvand M
    Semin Neurol; 2000; 20(1):7-20. PubMed ID: 10874773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of orbital muscles in treatment-resistant ophthalmoplegic myasthenia gravis.
    Europa TA; Nel M; Heckmann JM
    Orphanet J Rare Dis; 2020 Dec; 15(1):346. PubMed ID: 33308266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Mullaney P; Vajsar J; Smith R; Buncic JR
    Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis presenting with unusual neurogenic muscle atrophy.
    Samuraki M; Furui E; Komai K; Takamori M; Yamada M
    Muscle Nerve; 2007 Sep; 36(3):394-9. PubMed ID: 17326121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurogenic muscle involvement in myasthenia gravis. A clinical and histopathological study.
    Oosterhuis H; Bethlem J
    J Neurol Neurosurg Psychiatry; 1973 Apr; 36(2):244-54. PubMed ID: 4708458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Myasthenia.
    Al-Haidar M; Benatar M; Kaminski HJ
    Neurol Clin; 2018 May; 36(2):241-251. PubMed ID: 29655447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique subphenotype of myasthenia gravis.
    Heckmann JM; Nel M
    Ann N Y Acad Sci; 2018 Jan; 1412(1):14-20. PubMed ID: 28984362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.
    Sommer N; Melms A; Weller M; Dichgans J
    Doc Ophthalmol; 1993; 84(4):309-33. PubMed ID: 8156854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report.
    Ma R; Cheng Y; Gan L; Zhou X; Qian J
    BMC Ophthalmol; 2020 Apr; 20(1):166. PubMed ID: 32321476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limb muscle endplates in ocular myasthenia gravis: quantitative ultrastructural study.
    Tsujihata M; Hazama R; Ishii N; Ide Y; Mori M; Takamori M
    Neurology; 1979 May; 29(5):654-61. PubMed ID: 571563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Information furnished by electromyography of the ocular muscles during myasthenic ophthalmoplegias].
    PASSOUANT P; VIALLEFONT H; LETE E; COSTEAU J
    Rev Neurol (Paris); 1961 Feb; 104():147-52. PubMed ID: 13733183
    [No Abstract]   [Full Text] [Related]  

  • 17. Fine structure of neuromuscular junctions in myasthenic extraocular muscles.
    Sakimoto T; Cheng-Minoda K
    Invest Ophthalmol; 1970 Apr; 9(4):316-24. PubMed ID: 5435775
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysthyroid and myasthenic myopathy of the medial rectus: a clinical pathologic report.
    Spoor TC; Martinez AJ; Kennerdell JS; Mark LE
    Neurology; 1980 Sep; 30(9):939-44. PubMed ID: 7191538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome.
    Wirtz PW; Sotodeh M; Nijnuis M; Van Doorn PA; Van Engelen BG; Hintzen RQ; De Kort PL; Kuks JB; Twijnstra A; De Visser M; Visser LH; Wokke JH; Wintzen AR; Verschuuren JJ
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):766-8. PubMed ID: 12438488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research Advances in Ocular Myasthenia Gravis].
    Wu YJ; Yan L; Hu YX; Rao J; Xu XX; Cheng Y; Wu N; Wu XR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Jun; 41(3):402-407. PubMed ID: 31282337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.